Glaxis Capital Management, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison

Investment firm Glaxis Capital Management, LLC recently released its Q3 2022 and Q4 2022 13F holdings reports, revealing significant changes in its portfolio. In this article, we'll dive into some of the most noteworthy shifts and analyze the potential implications for investors.

Principal Financial Group Inc. Shows Strong Growth

Glaxis reported an increase of over 18% in Principal Financial Group Inc. holdings, with shares rising from 13,779 in Q3 to 14,005 in Q4. The firm also saw a notable jump in value, from $994,000 to $1,175,000. With Principal Financial Group Inc. being a leading provider of retirement solutions and asset management, it's clear that Glaxis sees potential for growth in this space.

Vaneck ETF Sees Massive Increase

Vaneck ETF Trust saw the largest percentage increase in holdings, with Glaxis reporting a massive jump from zero shares in Q3 to 5,000 in Q4. The value of these holdings was reported at $1,014,000. This shift suggests that Glaxis is bullish on the ETF market and sees potential for significant growth in the coming year.

Vanguard Holds Steady

Glaxis also reported steady increases in holdings of several Vanguard index funds, including Vanguard Index FDS and Vanguard Intl Equity Index F. Q3 to Q4 increases ranged from 7.9% to 21.4%, with corresponding increases in value reported as well. This steady growth indicates that Glaxis believes in the long-term potential of these funds and is committed to maintaining a diverse portfolio.

Microsoft Corp. and Medtronic Plc Hold Steady

Both Microsoft Corp. and Medtronic Plc remained flat in Glaxis' portfolio, with no change in shares held from Q3 to Q4. However, there was a small increase in value reported for Microsoft Corp., rising from $606,000 to $623,000. For Medtronic Plc, Glaxis reported a slight decrease in value from $646,000 to $621,000. While these holdings didn't experience significant growth, their stable presence in Glaxis' portfolio suggests confidence in their future performance.

Looking Ahead

Glaxis' shifts in holdings reveal a mix of high-growth potential and stable investments in their portfolio. With strong growth in Principal Financial Group Inc., Vaneck ETF Trust, and several Vanguard index funds, Glaxis seems to be optimistic about the coming year. Additionally, their commitment to maintaining holdings in Microsoft Corp. and Medtronic Plc suggests a long-term investment strategy.

Overall, Glaxis' Q3 and Q4 13F holdings reports provide valuable insights for investors looking to diversify their own portfolios. By analyzing the potential growth and stability of these investments, investors can make informed decisions about their own portfolios and achieve financial success.